Federal Supply Schedule GS07F0446V

Award Date 9/1/09
Last Date to Order 8/31/29
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
The Department of Veterans Affairs (VA) Veterans Health Administration has awarded a Blanket Purchase Agreement (BPA) to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics. The $487,747.35 BPA contract, issued under the GSA Schedule Critical Analyzers, Laboratory (FSS-66-III), will provide the VA with critical care analyzers, reagents, test kits, and associated laboratory equipment, supplies, and services. The contract supports the provision of...
The Department of Veterans Affairs (VA) Veterans Health Administration has awarded Roche Diagnostics Corporation, a foreign-owned manufacturer of in vitro diagnostics, an Indefinite Delivery Contract (IDC) to provide molecular pathology products and services. Under this IDC, the VA has issued multiple firm fixed-price delivery orders to Roche Diagnostics over a 5-year period, with a total ceiling value of $3,000,000. The delivery orders will supply clinical chemistry analyzers, reagents, test...
The U.S. Department of Veterans Affairs (VA) awarded a Blanket Purchase Agreement (BPA) to Roche Diagnostics Corporation, a foreign-owned manufacturer of in vitro diagnostics and medical products. The BPA, valued at $5,000,000, has a period of performance through June 30, 2029 and was not designated with a set-aside requirement, indicating open competition. Under this BPA, the VA has issued two task orders to Roche Diagnostics totaling $1,490,355.59. The task orders are for the procurement of...
The Department of Veterans Affairs (VA), Veterans Integrated Service Network 9 awarded an Indefinite Delivery Contract (IDC) to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer of in vitro diagnostics, reagents, and laboratory instruments. The base contract, valued at $922,772, provides the VA with an ongoing vehicle to procure influenza A/B and COVID-19 testing supplies and services without socioeconomic set-asides. Under this IDC, the VA has issued multiple firm...
The Department of Veterans Affairs (VA), through its Veterans Integrated Service Network 19 (VISN 19), has awarded a series of Blanket Purchase Agreement (BPA) call orders to Roche Diagnostics Corporation, a leading manufacturer and distributor of in vitro diagnostics, reagents, and laboratory instruments. These contract awards, valued at over $11 million collectively, provide VISN 19 with comprehensive chemistry and immunochemistry laboratory services, including testing equipment, reagents, and...
The Department of Veterans Affairs (VA) Veterans Health Administration awarded a Blanket Purchase Agreement (BPA) to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostic products, laboratory instruments, and associated medical equipment and supplies. The BPA, valued at up to $962,399.40, enables the VA's Veterans Integrated Service Network 17 to acquire Roche's Ventana Benchmark Ultra reagents, equipment, and supplies to support diagnostic pathology...
The Department of Veterans Affairs (VA), through the Veterans Integrated Service Network 20 (VISN 20), awarded Roche Diagnostics Corporation a Blanket Purchase Agreement (BPA) to provide chemistry analyzers and associated laboratory equipment, reagents, and services. The BPA was awarded under Roche's General Services Administration (GSA) Schedule 66-III contract for critical laboratory analyzers, with a total ceiling value of $397,419.19 and an ultimate completion date of June 30, 2024. Roche...
This Blanket Purchase Agreement (BPA) with Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, provides the Department of Veterans Affairs (VA) with laboratory instruments, reagents, test kits, and associated products and services. The 5-year BPA, valued at over $7 million, was awarded by the VA's Veterans Integrated Service Network 2 to supply chemistry and immunochemistry laboratory testing capabilities at VA hospitals in the Bronx, New York area. Roche Diagnostics, a...
The Department of Veterans Affairs (VA) Veterans Health Administration has awarded an Indefinite Delivery Contract (IDC) to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer, for immunochemistry and immunohistochemistry laboratory testing services. The single-award IDC, valued at $2.3 million, was awarded on November 13, 2020 and has an ultimate completion date of November 12, 2025. Under this IDC, the VA has placed multiple firm fixed price delivery orders with Roche...
Roche Diagnostics Corporation was awarded a multiple-award Federal Supply Schedule (FSS) contract by the U.S. Department of Veterans Affairs (VA) for in vitro diagnostics, reagents, and test kits. The 5-year contract, valued at up to $32.5 million, allows the VA and other federal agencies to acquire a wide range of Roche's medical equipment, laboratory instruments, and associated consumables on an as-needed basis. Under this FSS contract, Roche has received numerous delivery orders and blanket...

The Department of Veterans Affairs (VA) has awarded Roche Diagnostics Corporation, a foreign-owned manufacturer of in vitro diagnostics and medical equipment, multiple Indefinite Delivery Vehicles (IDVs) and Blanket Purchase Agreements (BPAs) through the General Services Administration (GSA) Multiple Award Schedule (MAS) contract. These IDVs and BPAs, valued between $400,000 and $520,000, provide Roche's critical care analyzers, reagents, test kits, and associated laboratory equipment, supplies, and services to support clinical testing and diagnostic capabilities at VA hospitals and other federal healthcare facilities nationwide.

The contracted products and services span a wide range of medical diagnostic technologies, including equipment such as COBAS analyzers, Ventana staining systems, LightCycler real-time PCR instruments, and associated reagents and consumables for detecting conditions like influenza, respiratory syncytial virus, and SARS-CoV-2. These IDVs and BPAs, established under Roche's GSA Schedule contracts, enable VA and other federal agencies to efficiently procure Roche's specialized laboratory solutions to support their healthcare missions. The contracts do not utilize any set-aside designations, indicating Roche competes openly in the federal marketplace for these awards.

Generated 6/18/25, 11:21 AM